Abstracts of the 22nd Meeting of the Interuniversity Institute of Myology
Vol. 36 No. s1 (2026): Abstract book of the Padua Days on Muscle and Mobility Medicine 2026
https://doi.org/10.4081/ejtm.2026.15062

Abstract 063 | Multifrequency phase angle as a clinical tool for healthspan interventions: towards sex-independent screening

Marta González Freire | Translational Research in Aging and Longevity - TRIAL group, Health Research Institute of the Balearic Islands - IdISBa, Spain.

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 2 March 2026
Published: 2 March 2026
85
Views
26
Downloads

Authors

Effective healthspan interventions require accessible biomarkers for early detection and monitoring (1). Phase angle (PhA) from bioelectrical impedance analysis offers a non-invasive, bedside marker of cellular health, but current sex-specific thresholds complicate clinical implementation (2,3). We evaluated whether multifrequency PhA assessment could provide a practical clinical tool for identifying individuals who would benefit from targeted interventions. Cross-sectional analysis of 83 community-dwelling adults (20-85 years) from the Balearic Islands Study of Aging (BILSA) cohort. PhA was measured at 5, 50, and 250 kHz using segmental BIA (InBody 770). We assessed: (1) which measurement protocol best identifies age-related decline; (2) frequency-specific associations with modifiable risk factors (muscle mass, visceral fat); and (3) whether sex-independent thresholds are achievable. Lower limb PhA emerged as the most sensitive early marker of biological aging (r=-0.57 vs r=-0.46 for whole body). Critically, 50 kHz and 250 kHz provide complementary clinical information: 50 kHz best predicts muscle mass (R²=0.59), guiding exercise interventions, while 250 kHz best predicts visceral fat (R²=0.36), guiding metabolic interventions. Most importantly for clinical implementation, sex differences disappear at 250 kHz (Cohen’s d=0.40, p=0.07), enabling potential universal screening thresholds. Prevalence of low PhA increased from 4% in young adults to 50% in elderly, identifying a substantial population for preventive intervention. In conclusion, Multifrequency PhA assessment provides an actionable clinical framework: leg PhA for early detection, 50 kHz for muscle-targeted interventions, and 250 kHz for metabolic interventions with sex-independent thresholds. This accessible approach could facilitate implementation of precision health span interventions in routine clinical practice.

Downloads

Download data is not yet available.

1. Ferrucci L, Gonzalez-Freire M, Fabbri E, et al. Measuring biological aging in humans: A quest. Aging Cell. 2020;19(2):e13080.

2. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing. 2019.

3. Rinaldi CA, Campa F, Toselli S, et al. Phase angle as a marker of muscular health and cellular integrity in aging: A narrative review. Nutrients. 2023;15(2):312.

How to Cite



1.
Freire MG. Abstract 063 | Multifrequency phase angle as a clinical tool for healthspan interventions: towards sex-independent screening: Marta González Freire | Translational Research in Aging and Longevity - TRIAL group, Health Research Institute of the Balearic Islands - IdISBa, Spain. Eur J Transl Myol [Internet]. 2026 Mar. 2 [cited 2026 Apr. 10];36(s1). Available from: https://www.pagepressjournals.org/bam/article/view/15062